Screening of metabolites in the treatment of liver cancer xenografts HepG2/ ADR by psoralen-loaded lipid nanoparticles

Li, LH; Zou, TT; Liang, M; Mezhuev, Y; Tsatsakis, AM; Dordevic, AB; Lan, M; Liu, FJ; Cai, TG; Gong, P; Cai, Y

Cai, TG; Gong, P; Cai, Y (corresponding author), Jinan Univ, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2021; 165 (): 337

Abstract

Objective: Our study aimed to find potential biomarkers for drug resistance in liver cancer cells using metabolomics and further to evaluate the poten......

Full Text Link